Please login to the form below
Graduate Programme
This page shows the latest Graduate Programme news and features for those working in and with pharma, biotech and healthcare.
GCI Health expands into Asia, Lucid adds to Futures Academy and more
Lucid has welcomed six new graduates into its training programme Futures Academy, which was launched in 2017. ... Ashfield’s medical writers graduate. Ashfield Healthcare Communications has seen its first cohort of medical writers graduate from
Latest news
-
Lucid’s first class of 2018 graduates from Lucid’s Futures Academy
Four graduates complete an eight-week training course. The Lucid Futures Academy, a graduate programme formed by medical communications company Lucid Group, has seen four of its new hires graduate after ... The programme currently runs as a biannual
-
News in Brief, May 30, 2007
The US Department of Health and Human Services has proposed regulations which would end federal matching funds paid to individual states for graduate medical education under the Medicaid programme. ... reimbursements, if states shift their own Medicaid
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
AXON Communications boosts senior team
Also joining AXON's senior team is Simonetta Ballali (pictured left), who becomes a programme director in the firm's medical communications stream. ... Meanwhile, Andy Scott (pictured below right) returns to AXON as an associate director, having first
-
Kantar Health adds to UK team
Group director, junior designers and graduate research team appointed. Global healthcare consulting firm Kantar Health has added five new recruits to its Epsom, UK-based team. ... Finally, we're delighted once again to be recruiting three such talented
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
A Magical Future – A year on from the graduate scheme
Emilie discusses her #LucidLife journey during the past year, after joining Lucid through their graduate scheme. ... I was greeted with a talented and passionate group of individuals with whom I would spend the next 8 weeks going through an intensive and
-
Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy
William Laudrum, graduate medical writer, commented, “With such a well-established graduate programme I felt confident that becoming a graduate medical writer at Lucid Group would be a great career opportunity ... Clare Reynolds, Director of Business
-
The Lucid Group Futures Academy welcomes its 2021 cohort
This week Lucid welcomed its newest cohort of graduates onto the 2021 Futures Academy programme. ... The programme provides graduates with a 12-month structured medical writing training programme.
-
For those who love science and storytelling — consider medical writing
Two years into my postdoc, I hung up the lab coat, moved to London and joined the Lucid Futures graduate programme, a competitive one-year training programme that combines ... My ability to quickly understand new scientific content and comfortably
-
Lucid Group kick starts its 2020 Futures Academy
This is Lucid’s fourth intake of graduates since the launch of its graduate training programme in October 2017. ... The programme has been extremely successful in enabling Lucid to tap into a new talent pool of highly motivated and educated individuals
More from PMHub
Approximately 8 fully matching, plus 10 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Rare diseases: not so rare after all
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- NHS England announces rare genetic disorder fast-tracking service
- NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
- Connectome competitiveness
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
